Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
4.88
-0.20 (-3.94%)
At close: Dec 29, 2023, 4:00 PM
4.93
+0.04 (0.92%)
After-hours: Dec 29, 2023, 4:03 PM EST
Akoya Biosciences Stock Forecast
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for AKYA stock stock is $8.00, which predicts an increase of 63.93%. The lowest target is $7.00 and the highest is $9.00. On average, analysts rate AKYA stock stock as a buy.
Analyst Consensus: Buy
* Price targets were last updated on Nov 13, 2023.
Analyst Ratings
The average analyst rating for AKYA stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 5 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 14, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $8 | Buy | Maintains | $11 → $8 | +63.93% | Nov 13, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $14 → $9 | Buy | Maintains | $14 → $9 | +84.43% | Nov 13, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $15 → $8 | Buy | Maintains | $15 → $8 | +63.93% | Oct 24, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +125.41% | Oct 16, 2023 |
Financial Forecast
Revenue This Year
98.65M
from 74.86M
Increased by 31.78%
Revenue Next Year
122.38M
from 98.65M
Increased by 24.06%
EPS This Year
-1.51
from -1.87
EPS Next Year
-1.01
from -1.51
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 102.5M | 132.5M | 175.3M | 190.6M | 224.5M | 262.6M |
| Avg | 98.6M | 122.4M | 151.4M | 185.1M | 218.1M | 255.1M |
| Low | 93.4M | 113.0M | 132.2M | 177.9M | 209.5M | 245.1M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 36.9% | 34.4% | 43.2% | 25.9% | 21.3% | 20.4% |
| Avg | 31.8% | 24.1% | 23.7% | 22.3% | 17.8% | 17.0% |
| Low | 24.8% | 14.5% | 8.0% | 17.5% | 13.2% | 12.4% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.39 | -0.88 | -0.53 | -0.30 | 0.07 | 0.37 |
| Avg | -1.51 | -1.01 | -0.68 | -0.30 | 0.07 | 0.36 |
| Low | -1.53 | -1.16 | -0.84 | -0.28 | 0.07 | 0.34 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | 414.7% |
| Avg | - | - | - | - | - | 400.0% |
| Low | - | - | - | - | - | 380.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.